Investment Summary

Investor AB Invests In AstraZeneca

On January 1, 1924, private equity firm Investor AB invested in life science company AstraZeneca

Investment Highlights
  • This is Investor AB’s 1st transaction in the Life Science sector.
  • This is Investor AB’s 1st transaction in the United Kingdom.

Investment Summary
Date 1924-01-01
Target AstraZeneca
Sector Life Science
Investor(s) Investor AB
Deal Type Stake Purchase

Target

AstraZeneca

Cambridge, United Kingdom
Main office on AstraZeneca's campus in Waltham, Massachusetts.
Main office on AstraZeneca's campus in Waltham, Massachusetts.
AstraZeneca is a global biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in several major disease areas, including oncology, cardiovascular, renal & metabolism, and respiratory & immunology. The Company's aim is to improve the health and quality of life of patients around the world through medicines, treatment solutions, and accessibility to healthcare. AstraZeneca is involved in both the research and development (R&D) and manufacturing of drugs to address critical areas of unmet medical need. AstraZeneca was founded in 1992 and is based in Cambridge, United Kingdom.

Search 197,704 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Investor AB

Stockholm, Sweden

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1916
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Investor AB is a Northern European industrial holding company. Investor generates long-term returns by investing in companies with solid potential for value creation. Investor will consider opportunities in the US, Northern Europe and Asia. Investor AB is based Stockholm.

DEAL STATS #
Overall 1 of 14
Sector (Life Science) 1 of 2
Type (Stake Purchase) 1 of 9
Country (United Kingdom) 1 of 1
Year (1924) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
1925-01-01 ABB

Zurich, Switzerland

ABB is an engineering company that helps customers use electrical power effectively and increase industrial productivity in a sustainable way. ABB creates and supports a range of products, systems and services that increase energy efficiency, reliability and productivity for a variety of industrial, utility, and transport and infrastructure customers. ABB was founded in 1883 and is based in Zurich, Switzerland.

Buy -
Mergr

Product

Company

Legal